Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men.

Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men. Abstract Text:

Jaakko Puttonen,Tarmo Laine,Meri Ramela,Sari ,Wenhui Zhang,Rajendra Pradhan,Pertti ,Mikko Koskinen,Jaakko Puttonen,Tarmo Laine,Meri Ramela,Sari ,Wenhui Zhang,Rajendra Pradhan,Pertti ,Mikko Koskinen,

OBJECTIVE: To investigate the pharmacokinetics and excretion balance of [(14)C]-OR-1896, a pharmacologically active metabolite of levosimendan, in six healthy male subjects. In addition, pharmacokinetic parameters of total radiocarbon and the deacetylated congener, OR-1855, were determined. METHODS: OR-1896 was administered as a single intravenous infusion of 200mug of [(14)C]-OR-1896 (specific activity 8.6MBq/mg) over 10min. The pharmacokinetic parameters were calculated by three-compartmental methods. RESULTS: During the 14-day collection of urine and faeces, excretion (+/-S.D.) averaged 94.2+/-1.4% of the [(14)C]-OR-1896 dose. Mean recovery of radiocarbon in urine was 86.8+/-1.9% and in faeces 7.4+/-1.5%. Mean terminal elimination half-life of OR-1896 (t(1/2)) was 70.0+/-44.9h. Maximum concentrations of OR-1855 were approximately 30% to that of OR-1896. Total clearance and the volume of distribution of OR-1896 were 2.0+/-0.4l/h and 175.6+/-74.5l, respectively. Renal clearances of OR-1896 and OR-1855 were 0.9+/-0.4l/h and (5.4+/-2.3)x10(-4)l/h, respectively. CONCLUSIONS: This study provides data to demonstrate that nearly one half of OR-1896 is eliminated unchanged into urine and that the active metabolites metabolite of levosimendan remain in the body longer than levosimendan. The remaining half of OR-1896 dose is eliminated through other metabolic routes, partially through interconversion back to OR-1855 with further metabolism of OR-1855. Given the fact that the pharmacological activity and potency of OR-1896 is similar to levosimendan, these results emphasize the clinical significance of OR-1896 and its contribution to the long-lasting effects of levosimendan.

Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men. Publishing Authors By Initials

J Puttonen,T Laine,M Ramela,S ,W Zhang,R Pradhan,P ,M Koskinen,J Puttonen,T Laine,M Ramela,S ,W Zhang,R Pradhan,P ,M Koskinen,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: European journal of pharmaceutical sciences : offi

VOLUME: 32

Page Numbers: 271-7

Journal Abbreviation:

ISSN: 0928-0987

DAY: 10

MONTH: 08

YEAR: 2007

Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9317982

Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men.

AFFILIATION: Research and Development, Orion Pharma, P.O. Box 1780, FIN-70701 Kuopio, Finland; Department of Pharmaceutics, University of Kuopio, Finland.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur J Pharm Sci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men Related Publications

• A plausible biogenetic proposal for koumine.
• Adaptive sutures. Changes after unilateral masticatory muscle resection in rats. A microscopic study.
• Ankle and foot injuries: analysis of MDCT findings.
• Assessment of automated scintigram alignment in the stackgram domain for cardiac stress-rest SPECT studies.
• Coronary heart disease among diabetic and nondiabetic people - socioeconomic differences in incidence, prognosis and mortality.
• Cytology of the liver in ileus; a study based on liver biopsies.
• Degradation and sorption of imidacloprid in dissimilar surface and subsurface soils.
• Differential early ERPs to fearful versus neutral facial expressions: A response to the salience of the eyes?
• Direct and indirect selection of visceral lipid weight, fillet weight, and fillet percentage in a rainbow trout breeding program.
• Dissolution of dentin by endodontic irrigants.
• Evaluation of methods and effects of endodontic irrigants in the preparation of root canals.
• Experimental Investigation of Angular Stackgram Filtering for Noise Reduction of SPECT Projection Data: Study with Linear and Nonlinear Filters.
• Histologic evaluation of periapical areas of endodontically treated teeth with unsuccessful healing.
• Large parameniscal cysts of the knee with the relation to the cystic changes of the menisci.
• Living arrangements, heavy drinking and alcohol dependence.
• Pancytopenia during salazopyrin treatment; a case report.
• Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men.
• Renal perfusion in experimental coarctation of the aorta during antihypertensive therapy.
• Serum vitamin A and E levels in patients with lichen sclerosus and carcinoma of the vulva--effect of oral etretinate treatment.
• Thalamic deep brain stimulation in the treatment of essential tremor: a long-term follow-up.
• The effect of social capital on health: The case of two language groups in Finland.
• The effects of long-term anticonvulsant drug therapy on vitamin D metabolites and mineral homeostasis in pregnant epileptic women and their newborns.
• The mediating role of C-reactive protein and handgrip strength between obesity and walking limitation.
• The repair of experimental fractures under the action of growth hormone, thyrotropin and cortisone. A tissue analytic, roentgenologic and autoradiographic study.
• The retention of screw posts in root canals.
• The value of the disc operation in prolonged disabling sciatica; a clinical study with an evaluation of results and symptoms based on follow-up examination of 104 cases.
• Timing and value of protocol biopsies in well-matched kidney transplant recipients--a clinical and histopathologic analysis.
• [First aid in pulp and root therapy]
• [In Process Citation]
• [Not Available.]